Bicycle Therapeutics Appoints Dr. Dominic Smethurst as Chief Medical Officer

CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle┬«) technology, today announced…